4.7 Article

Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical features

期刊

COMMUNICATIONS BIOLOGY
卷 4, 期 1, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s42003-021-02036-x

关键词

-

资金

  1. National Key Research and Development Program of China [2018YFC2000500]
  2. National Natural Science Foundation of China [81800457, 81790631, 81570512]
  3. National Science and Technology Major Project [2017ZX10204401]
  4. Zhejiang Province key research and development plan emergency project [2020C03123]
  5. Zhejiang Provincial Natural Science Foundation of China [LED20H190001, LQ19H030007]

向作者/读者索取更多资源

The study reveals that gut mycobiota dysbiosis occurs in both COVID-19 patients and H1N1-infected patients, and this dysbiosis does not improve until patients are discharged and no longer require medical attention.
The relationship between gut microbes and COVID-19 or H1N1 infections is not fully understood. Here, we compared the gut mycobiota of 67 COVID-19 patients, 35 H1N1-infected patients and 48 healthy controls (HCs) using internal transcribed spacer (ITS) 3-ITS4 sequencing and analysed their associations with clinical features and the bacterial microbiota. Compared to HCs, the fungal burden was higher. Fungal mycobiota dysbiosis in both COVID-19 and H1N1-infected patients was mainly characterized by the depletion of fungi such as Aspergillus and Penicillium, but several fungi, including Candida glabrata, were enriched in H1N1-infected patients. The gut mycobiota profiles in COVID-19 patients with mild and severe symptoms were similar. Hospitalization had no apparent additional effects. In COVID-19 patients, Mucoromycota was positively correlated with Fusicatenibacter, Aspergillus niger was positively correlated with diarrhoea, and Penicillium citrinum was negatively correlated with C-reactive protein (CRP). In H1N1-infected patients, Aspergillus penicilloides was positively correlated with Lachnospiraceae members, Aspergillus was positively correlated with CRP, and Mucoromycota was negatively correlated with procalcitonin. Therefore, gut mycobiota dysbiosis occurs in both COVID-19 patients and H1N1-infected patients and does not improve until the patients are discharged and no longer require medical attention. Lv et al. associate the gut mycobiota with clinical features and the bacterial microbiota by comparing COVID-19 patients to those infected with H1N1 and healthy controls. They find that gut mycobiota dysbiosis occurs in both COVID-19 patients and those infected with H1N1 and that it does not improve until patients no longer require medical attention, providing insights into a better healthcare guideline.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据